IDYA
Ideaya Biosciences Inc

1,292
Mkt Cap
$2.65B
Volume
1.19M
52W High
$39.28
52W Low
$13.45
PE Ratio
-16.32
IDYA Fundamentals
Price
$30.27
Prev Close
$31.52
Open
$31.14
50D MA
$34.47
Beta
1.17
Avg. Volume
934,644.10
EPS (Annual)
-$3.36
P/B
2.43
Rev/Employee
$53,435.11
$1,441.98
Loading...
Loading...
News
all
press releases
IDEAYA Biosciences (IDYA) Expected to Announce Quarterly Earnings on Thursday
IDEAYA Biosciences (NASDAQ:IDYA) will be releasing its Q4 2025 earnings before the market opens on Thursday, February 12. (View Earnings Report at...
MarketBeat·12d ago
News Placeholder
More News
News Placeholder
IDEAYA Biosciences, Inc. $IDYA Shares Acquired by New York State Common Retirement Fund
New York State Common Retirement Fund lifted its position in shares of IDEAYA Biosciences, Inc. (NASDAQ:IDYA - Free Report) by 21.7% in the 3rd quarter, according to the company in its most recent...
MarketBeat·14d ago
News Placeholder
Knights of Columbus Asset Advisors LLC Invests $934,000 in IDEAYA Biosciences, Inc. $IDYA
Knights of Columbus Asset Advisors LLC bought a new stake in IDEAYA Biosciences, Inc. (NASDAQ:IDYA - Free Report) during the third quarter, according to the company in its most recent Form 13F filing...
MarketBeat·16d ago
News Placeholder
IDEAYA Biosciences Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
IDEAYA Biosciences Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4) IDEAYA Biosciences Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4) PR Newswire SOUTH SAN...
PR Newswire·18d ago
News Placeholder
IDEAYA Biosciences, Inc. (NASDAQ:IDYA) Given Consensus Recommendation of "Moderate Buy" by Brokerages
Shares of IDEAYA Biosciences, Inc. (NASDAQ:IDYA - Get Free Report) have been given a consensus rating of "Moderate Buy" by the seventeen analysts that are covering the company, Marketbeat Ratings...
MarketBeat·21d ago
News Placeholder
IDEAYA Biosciences, Inc. $IDYA Stake Lifted by SG Americas Securities LLC
SG Americas Securities LLC boosted its stake in IDEAYA Biosciences, Inc. (NASDAQ:IDYA - Free Report) by 169.1% during the 3rd quarter, according to its most recent Form 13F filing with the Securities...
MarketBeat·1mo ago
News Placeholder
Day One Biopharmaceuticals (DAWN) Surges 26.7%: Is This an Indication of Further Gains?
Day One Biopharmaceuticals (DAWN) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
Zacks·1mo ago
News Placeholder
IDYA March 20th Options Begin Trading
Investors in IDEAYA Biosciences Inc (Symbol: IDYA) saw new options begin trading today, for the March 20th expiration. One of the key inputs that goes into the price an option buyer is willing to...
Nasdaq News: Markets·1mo ago
News Placeholder
IDEAYA Biosciences Announces Participation at the 44th Annual J.P. Morgan Healthcare Conference
IDEAYA Biosciences Announces Participation at the 44th Annual J.P. Morgan Healthcare Conference IDEAYA Biosciences Announces Participation at the 44th Annual J.P. Morgan Healthcare Conference PR...
PR Newswire·1mo ago
News Placeholder
IDEAYA Biosciences, Inc. (NASDAQ:IDYA) Receives Consensus Recommendation of "Moderate Buy" from Brokerages
Shares of IDEAYA Biosciences, Inc. (NASDAQ:IDYA - Get Free Report) have earned a consensus rating of "Moderate Buy" from the sixteen analysts that are covering the firm, Marketbeat.com reports. One...
MarketBeat·2mo ago
<
1
2
...
>

Latest IDYA News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.